Questions: Proteasomal Degradation and Ubiquitin-Mediated Marking

Question 1

A cell biologist attaches a single ubiquitin molecule to a target protein and tracks whether it gets degraded by the proteasome. What result should they expect, and why?

• A. The protein will be rapidly degraded — any ubiquitin attachment signals proteasomal destruction
• B. The protein will not be degraded by the proteasome — a single ubiquitin is insufficient; K48-linked polyubiquitin chains of at least four subunits are required for proteasomal targeting
• C. The protein will be degraded more slowly than a polyubiquitinated protein, since degradation rate scales linearly with ubiquitin count
• D. The protein will be degraded because the proteasome cannot distinguish mono- from polyubiquitin chains

Answer: (B)

Monoubiquitination is not a degradation signal — it serves other cellular functions such as directing membrane proteins to endosomes and regulating DNA repair. Proteasomal targeting specifically requires a K48-linked polyubiquitin chain of at least four ubiquitins, recognized by specific ubiquitin receptors on the 26S proteasome. Options A and D represent the common misconception that any ubiquitin attachment triggers degradation. Option C is also wrong — the signal is qualitative (sufficient chain length and topology), not a simple linear quantity.

Question 2

A researcher discovers a compound that inhibits all E3 ubiquitin ligases simultaneously. What would be the primary consequence for cell cycle progression?

• A. Cells would cycle faster because cyclin proteins would accumulate and drive continuous progression
• B. Cells would arrest because cyclin proteins could not be degraded at the correct time to allow phase transitions
• C. Cells would be unaffected because the cell cycle depends on cyclin synthesis, not degradation
• D. Cells would arrest because E3 ligases also function as transcription factors required for cyclin gene expression

Answer: (B)

Cell cycle transitions require the timely destruction of cyclins, not just their synthesis. The APC/C — a key E3 ligase — ubiquitinates cyclins and securin at precise moments to enable the next phase. Without E3 ligase activity, cyclins accumulate beyond their normal window, preventing the transitions that require their removal. Bortezomib, a proteasome inhibitor used as a cancer drug, exploits this principle — causing toxic protein accumulation. Option C is the main misconception to correct: degradation, not just synthesis, is how the cell cycle timing is enforced.

Question 3

Ubiquitination is an irreversible modification — once a protein is marked with ubiquitin, it will inevitably be degraded by the proteasome.

• T. True
• F. False

Answer: False

Deubiquitinating enzymes (DUBs) can remove ubiquitin chains from proteins, rescuing them from degradation. Some DUBs act at the proteasome entrance to recycle ubiquitin before the protein is threaded into the barrel; others act earlier in the pathway to reverse the ubiquitination decision entirely. This reversibility means ubiquitination is a dynamic regulatory signal that can be overwritten in response to cellular conditions — not a one-way death sentence.

Question 4

The E3 ubiquitin ligases are the key determinants of which specific proteins get targeted for degradation, because they directly recognize degradation signals (degrons) on substrate proteins.

• T. True
• F. False

Answer: True

The E1-E2-E3 cascade is a funnel: there are only ~2 E1 enzymes and ~40 E2 enzymes in humans, but over 600 E3 ligases, each recognizing specific degrons. Substrate specificity lives almost entirely in the E3. Degrons can be constitutive (always exposed) or conditional (exposed only after phosphorylation, misfolding, or oxidation), allowing cells to regulate which proteins are destroyed in response to specific signals. This is how the ubiquitin-proteasome system functions as a precision regulatory mechanism, not just a garbage disposal.

Question 5

What distinguishes K48-linked polyubiquitin chains from monoubiquitination in terms of cellular fate, and why is this distinction important for understanding protein regulation?

Model answer: Monoubiquitination — a single ubiquitin on a lysine — does not signal proteasomal degradation. It serves other functions: directing membrane proteins to endosomes, regulating DNA repair, and modifying histones. Proteasomal degradation requires a K48-linked polyubiquitin chain of at least four ubiquitins, which is specifically recognized by ubiquitin receptors on the 26S proteasome. This means the cell can use ubiquitin as a multifunctional signal on the same protein at different times — monoubiquitination can change a protein's localization without destroying it, and subsequent K48 chain extension can later trigger degradation. The chain type and length encode distinct fates.

This topology-dependent specificity is analogous to how phosphorylation at different sites can activate or inhibit the same protein. The ubiquitin code uses chain length, linkage type, and branching to encode a diverse range of cellular decisions beyond simple degradation.